![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif)
enoxaparin A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells. Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif)
Synonym: | ![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif) | Enoxaparin Sodium | | ![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif) | US brand name: | ![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif) | Lovenox | | ![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081005063559im_/http://www.nci.nih.gov/images/spacer.gif) |